What is Tirzepatide? The Research Compound Behind Mounjaro

Tirzepatide is a dual GIP and GLP-1 receptor research peptide. It is the active compound behind the brand Mounjaro. Here is what researchers need to know.

How tirzepatide works

Tirzepatide activates two receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1. This dual action is why it is studied differently from single-receptor peptides.

Research applications

Tirzepatide is studied in metabolic research, weight management research and glucose regulation protocols. It is a research compound and is not approved for human use.

Buying tirzepatide research peptide in Egypt

We supply tirzepatide 60mg research vials in Egypt, batch SP-2608-T60, documented with the report we hold and its limits stated. The certificate shows purity results for the tested batch. Every vial is batch-coded and delivered for 200 EGP to any city in Egypt.

Important

Mounjaro is a registered medicine. We do not sell Mounjaro. We supply tirzepatide for research and laboratory use only, not for human or veterinary use.

View Tirzepatide 60mg · View certificate